NNE Pharmaplan
Michael Hallgren is Senior Vice President of Diabetes Active Pharmaceutical Ingredients at Novo Nordisk A/S, which he joined in 1994. In addition to his NNE Board role, Michael is Chairman of Kalundborg Symbiosis and member of the Board of Directors at Novo Nordisk Pharmatech A/S.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
NNE Pharmaplan
Selskabets formål er at udføre rådgivende ingeniørvirksomhed og aktiviteter i naturlig tilknytning hertil.